http://www.InteretTherapeutique.org/grossesse/ New studies included in the knowledge base of medication and pregnancy en studies http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Elshony, H. et al. Pregnancy and primary epilepsy: the interwoven effects on seizure dynamics, AED management, and fetal well-being? Egypt. J. Neurol., Psychiatr. Neurosurg. 2026; 62:-.http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Saramak et al. Lacosamide safety during pregnancy and Breastfeeding: A Single-Centre Experience and Comprehensive Narrative Review . Pharm. 2026; 14:443-. [PMID: ] doi: 10.3390/pharmacy14020058http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Jedrzejczak, J. et al. Congenital malformations in the offspring of women with epilepsy: a two-decade experience in Poland J. Epileptol 2025; 33:3-.http://www.txrating.org/grossesse/viewMA.aspx?exposition=1247Kim et al. Prenatal Exposure to Antiseizure Medications and the Risk of Congenital Anomalies: A Nationwide Population-Based Study in South Korea. Neurology 2026; 106:e214350http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Kalyanasundaram et al. Impact of valproate discontinuation on seizure control in women of reproductive age. Epileptic Disord 2026; :http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Duchemin et al. Identification of major congenital malformations based on healthcare databases in France: A proof-of-concept study using the epi-meres nationwide mother-child register. Br J Clin Pharmacol 2026; :http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Umer et al. Gabapentin and Opioid Coexposure During Pregnancy and Adverse Perinatal Outcomes: A Population-Based Study, 2020-2024. Am J Perinatol 2026; :http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Lopes et al. Pregnancy outcomes following Eslicarbazepine acetate exposure in women with epilepsy: A global safety database analysis from clinical development to 16 years of post-marketing experience. Seizure 2026; 140:62-68http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Honybun et al. Neurocognitive Outcomes of In Utero Exposure to Antiseizure Medication: An Australian Cohort Study. Neurology 2026; 107:e218122http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Beau et al. Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study. Drug Saf 2026; :